|
1
|
Pillai JR, Wali AF, Shivappa P, Talath S, Attia SM, Nadeem A, Rehman MU. Evaluating the anti-cancer potential and pharmacological in-sights of Physalis angulata Root Extract as a strong candidate for future research. J Genet Eng Biotechnol 2024; 22:100410. [PMID: 39674639 PMCID: PMC11387689 DOI: 10.1016/j.jgeb.2024.100410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2024] [Revised: 07/29/2024] [Accepted: 08/08/2024] [Indexed: 12/16/2024]
Abstract
The research targeting the prevention of complications through natural constituents, instigated by the cancer has recently drawn much more attention over the globe. The research in this direction also revealed that the use of natural constituents would considered a promising strategy for diminishing the aforementioned disease and its consequences. Because of the easy availability and safe nature, the recent years, natural resources as strong anticancer agents. In this regard, here we introduced the possibility of using the methanolic extract of Physalis angulata root as a strong candidate and implemented the applicability of LC-MS to unveil the presence of various phytocompounds. The anticancer potential exhibited by Physalis angulata root followed by its ability to induce toxicity against the microbial population enhanced the interest in unveiling the phytochemical compounds including Absintholide, Curcumin dimer 1, Mytilin A, Ginsenoside F1, Encecalin , Ganoderic acid TQ, Alnustone, Rhamnetin 3-sophoroside, Gibberellin A14 aldehyde, Thiolutin, Euglobal III and Epomusenin B. The presence of various macro and micronutrients suggested that Physalis angulata is a prominent resource for future research targeting pharmacological research, especially anticancer research.
Collapse
Affiliation(s)
- Jayachithra Ramakrishna Pillai
- Department of Pharmaceutical Chemistry, RAK Medical and Health Sciences University, Ras Al Khaimah, 11172, United Arab Emirates.
| | - Adil Farooq Wali
- Department of Pharmaceutical Chemistry, RAK Medical and Health Sciences University, Ras Al Khaimah, 11172, United Arab Emirates; Pharmaceutical Chemistry Division, Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar 190006, Jammu and Kashmir, India.
| | - Pooja Shivappa
- Translational Medicinal Research Centre, Department of Biochemistry, RAK Medical and Health Sciences University, Ras Al Khaimah, 11172, United Arab Emirates.
| | - Sirajunisa Talath
- Department of Pharmaceutical Chemistry, RAK Medical and Health Sciences University, Ras Al Khaimah, 11172, United Arab Emirates.
| | - Sabry M Attia
- Department of Pharmacology & Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
| | - Ahmed Nadeem
- Department of Pharmacology & Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
| | - Muneeb U Rehman
- Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
| |
Collapse
|
|
2
|
Ilie EI, Popescu L, Luță EA, Biță A, Corbu AR, Mihai DP, Pogan AC, Balaci TD, Mincă A, Duțu LE, Olaru OT, Boscencu R, Gîrd CE. Phytochemical Characterization and Antioxidant Activity Evaluation for Some Plant Extracts in Conjunction with Pharmacological Mechanism Prediction: Insights into Potential Therapeutic Applications in Dyslipidemia and Obesity. Biomedicines 2024; 12:1431. [PMID: 39062004 PMCID: PMC11274650 DOI: 10.3390/biomedicines12071431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2024] [Revised: 06/21/2024] [Accepted: 06/25/2024] [Indexed: 07/28/2024] Open
Abstract
Lipid metabolism dysregulation can lead to dyslipidemia and obesity, which are major causes of cardiovascular disease and associated mortality worldwide. The purpose of the study was to obtain and characterize six plant extracts (ACE-Allii cepae extractum; RSE-Rosmarini extractum; CHE-Cichorii extractum; CE-Cynarae extractum; AGE-Apii graveolentis extractum; CGE-Crataegi extractum) as promising adjuvant therapies for the prevention and treatment of dyslipidemia and its related metabolic diseases. Phytochemical screening revealed that RSE was the richest extract in total polyphenols (39.62 ± 13.16 g tannic acid/100 g dry extract) and phenolcarboxylic acids (22.05 ± 1.31 g chlorogenic acid/100 g dry extract). Moreover, the spectrophotometric chemical profile highlighted a significant concentration of flavones for CGE (5.32 ± 0.26 g rutoside/100 g dry extract), in contrast to the other extracts. UHPLC-MS quantification detected considerable amounts of phenolic constituents, especially chlorogenic acid in CGE (187.435 ± 1.96 mg/g extract) and rosmarinic acid in RSE (317.100 ± 2.70 mg/g extract). Rosemary and hawthorn extracts showed significantly stronger free radical scavenging activity compared to the other plant extracts (p < 0.05). Pearson correlation analysis and the heatmap correlation matrix indicated significant correlations between phytochemical contents and in vitro antioxidant activities. Computational studies were performed to investigate the potential anti-obesity mechanism of the studied extracts using target prediction, homology modeling, molecular docking, and molecular dynamics approaches. Our study revealed that rosmarinic acid (RA) and chlorogenic acid (CGA) can form stable complexes with the active site of carbonic anhydrase 5A by either interacting with the zinc-bound catalytic water molecule or by directly binding Zn2+. Further studies are warranted to experimentally validate the predicted CA5A inhibitory activities of RA and CGA and to investigate the hypolipidemic and antioxidant activities of the proposed plant extracts in animal models of dyslipidemia and obesity.
Collapse
Affiliation(s)
- Elena Iuliana Ilie
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (E.I.I.); (E.-A.L.); (A.C.P.); (T.D.B.); (L.E.D.); (O.T.O.); (R.B.); (C.E.G.)
| | - Liliana Popescu
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (E.I.I.); (E.-A.L.); (A.C.P.); (T.D.B.); (L.E.D.); (O.T.O.); (R.B.); (C.E.G.)
| | - Emanuela-Alice Luță
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (E.I.I.); (E.-A.L.); (A.C.P.); (T.D.B.); (L.E.D.); (O.T.O.); (R.B.); (C.E.G.)
| | - Andrei Biță
- Department of Pharmacognosy & Phytotherapy, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, Petru Rareș 2, 200349 Craiova, Romania;
| | - Alexandru Radu Corbu
- Department of Horticulture & Food Science, University of Craiova, AI Cuza 13, 200585 Craiova, Romania;
| | - Dragoș Paul Mihai
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (E.I.I.); (E.-A.L.); (A.C.P.); (T.D.B.); (L.E.D.); (O.T.O.); (R.B.); (C.E.G.)
| | - Ana Corina Pogan
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (E.I.I.); (E.-A.L.); (A.C.P.); (T.D.B.); (L.E.D.); (O.T.O.); (R.B.); (C.E.G.)
| | - Teodora Dalila Balaci
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (E.I.I.); (E.-A.L.); (A.C.P.); (T.D.B.); (L.E.D.); (O.T.O.); (R.B.); (C.E.G.)
| | - Alexandru Mincă
- Department of Medical Semiology, Discipline of Internal Medicine I and Nephrology, Faculty of Medicine, University of Medicine and Pharmacy “Carol Davila”, Eroii Sanitari 8, 050474 Bucharest, Romania;
| | - Ligia Elena Duțu
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (E.I.I.); (E.-A.L.); (A.C.P.); (T.D.B.); (L.E.D.); (O.T.O.); (R.B.); (C.E.G.)
| | - Octavian Tudorel Olaru
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (E.I.I.); (E.-A.L.); (A.C.P.); (T.D.B.); (L.E.D.); (O.T.O.); (R.B.); (C.E.G.)
| | - Rica Boscencu
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (E.I.I.); (E.-A.L.); (A.C.P.); (T.D.B.); (L.E.D.); (O.T.O.); (R.B.); (C.E.G.)
| | - Cerasela Elena Gîrd
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (E.I.I.); (E.-A.L.); (A.C.P.); (T.D.B.); (L.E.D.); (O.T.O.); (R.B.); (C.E.G.)
| |
Collapse
|
|
3
|
Ivan IM, Olaru OT, Popovici V, Chițescu CL, Popescu L, Luță EA, Ilie EI, Brașoveanu LI, Hotnog CM, Nițulescu GM, Boscencu R, Gîrd CE. Antioxidant and Cytotoxic Properties of Berberis vulgaris (L.) Stem Bark Dry Extract. Molecules 2024; 29:2053. [PMID: 38731544 PMCID: PMC11085362 DOI: 10.3390/molecules29092053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2024] [Revised: 04/26/2024] [Accepted: 04/27/2024] [Indexed: 05/13/2024] Open
Abstract
Berberis vulgaris (L.) has remarkable ethnopharmacological properties and is widely used in traditional medicine. The present study investigated B. vulgaris stem bark (Berberidis cortex) by extraction with 50% ethanol. The main secondary metabolites were quantified, resulting in a polyphenols content of 17.6780 ± 3.9320 mg Eq tannic acid/100 g extract, phenolic acids amount of 3.3886 ± 0.3481 mg Eq chlorogenic acid/100 g extract and 78.95 µg/g berberine. The dried hydro-ethanolic extract (BVE) was thoroughly analyzed using Ultra-High-Performance Liquid Chromatography coupled with High-Resolution Mass Spectrometry (UHPLC-HRMS/MS) and HPLC, and 40 bioactive phenolic constituents were identified. Then, the antioxidant potential of BVE was evaluated using three methods. Our results could explain the protective effects of Berberidis cortex EC50FRAP = 0.1398 mg/mL, IC50ABTS = 0.0442 mg/mL, IC50DPPH = 0.2610 mg/mL compared to ascorbic acid (IC50 = 0.0165 mg/mL). Next, the acute toxicity and teratogenicity of BVE and berberine-berberine sulfate hydrate (BS)-investigated on Daphnia sp. revealed significant BS toxicity after 24 h, while BVE revealed considerable toxicity after 48 h and induced embryonic developmental delays. Finally, the anticancer effects of BVE and BS were evaluated in different tumor cell lines after 24 and 48 h of treatments. The MTS assay evidenced dose- and time-dependent antiproliferative activity, which was higher for BS than BVE. The strongest diminution of tumor cell viability was recorded in the breast (MDA-MB-231), colon (LoVo) cancer, and OSCC (PE/CA-PJ49) cell lines after 48 h of exposure (IC50 < 100 µg/mL). However, no cytotoxicity was reported in the normal epithelial cells (HUVEC) and hepatocellular carcinoma (HT-29) cell lines. Extensive data analysis supports our results, showing a significant correlation between the BVE concentration, phenolic compounds content, antioxidant activity, exposure time, and the viability rate of various normal cells and cancer cell lines.
Collapse
Affiliation(s)
- Ionuț Mădălin Ivan
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| | - Octavian Tudorel Olaru
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| | - Violeta Popovici
- Center for Mountain Economics, “Costin C. Kiriţescu” National Institute of Economic Research (INCE-CEMONT), Romanian Academy, 725700 Vatra-Dornei, Romania
| | - Carmen Lidia Chițescu
- Faculty of Medicine and Pharmacy, “Dunărea de Jos” University of Galați, A.I. Cuza 35, 800010 Galați, Romania;
| | - Liliana Popescu
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| | - Emanuela Alice Luță
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| | - Elena Iuliana Ilie
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| | - Lorelei Irina Brașoveanu
- Center of Immunology, “Stefan S. Nicolau” Institute of Virology, Romanian Academy, 285 Mihai Bravu Ave., 030304 Bucharest, Romania; (L.I.B.); (C.M.H.)
| | - Camelia Mia Hotnog
- Center of Immunology, “Stefan S. Nicolau” Institute of Virology, Romanian Academy, 285 Mihai Bravu Ave., 030304 Bucharest, Romania; (L.I.B.); (C.M.H.)
| | - George Mihai Nițulescu
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| | - Rica Boscencu
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| | - Cerasela Elena Gîrd
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| |
Collapse
|